LISATA THERAPEUTICS, INC. Impairment of Long-Lived Assets to be Disposed of
LISATA THERAPEUTICS, INC. (LSTA) reported Impairment of Long-Lived Assets to be Disposed of of -$1.38 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2018-08-09
- LISATA THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2018-06-30 was -$1.38M, a 1173.03% decline year-over-year.
- LISATA THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2017-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2017-06-30 was $128.49K.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month |
|---|---|---|---|
| 2018-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.38M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $128.49K derived: sum of 2 quarters · filed 2018-08-09 | $175.79K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $128.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $175.79K 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $47.30K 10-Q · filed 2018-05-10 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $591.31K 10-Q · filed 2017-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $591.31K 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $591.31K 10-Q · filed 2017-05-15 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |